Naveen Kumar Vishvakarma
Professor
Work Experience
28th July 2023 to till date Professor -Biotechnology Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh 20th Jan, 2014 to 27th July 2023 Assistant Professor -Biotechnology Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh 14th June, 2013 to 16th Jan, 2014 Assistant Professor-Microbiology Department of Botany and Microbiology, HNB Garhwal University-Uttarakhand 29th April 2012 to 11th June 2013 Post-Doctoral Fellow Cancer Imaging and Metabolism, Moffitt Cancer Center and Research Institute, USA 06th July, 2011 to 23rd April 2012 ICMR-Research Associate School of Biotechnology Banaras Hindu University-UP 29 Nov, 2010 to 30 Dec, 2010 Post-Doctoral Fellow Manitoba Institute of Cell Biology, Cancer Care Manitoba, Winnipeg-Manitoba, Canada 01st July, 2009 - 30th March 2011 CSIR-Junior Research Fellow School of Biotechnology Banaras Hindu University-UP 28th Jan, 2008 to 30th June 2010 UGC –Research Fellow School of Biotechnology Banaras Hindu University, UP 04th March 2006 to 18th Jan 2008 Assistant Professor- Microbiology Department of Microbiology VBS Purvanchal University, UP
Area of Specialization
Cancer Biology and Immunology
Projects & Patents
1. Evaluation of curcumin as modulator of tumor metabolism: implication in antineoplastic therapy. 2015-2017. UGC-BSR-Start-Up Research Grant: PI: 6.00 Lakhs 2. Targeting tumor metabolism by curcumin as a novel antineoplastic approach. 2016-2019. UGC-Major Research Project.: PI: 14.50 Lakhs
Education
M.Sc. Applied Microbiology from VBS Purvanchal University, Jaunpur, UP Ph.D. Biotechnology, Banaras Hindu University, UP
Achievments/Awards/Honors
Publications
Peer Reviewed Journal Publication * denotes corresponding author 1. Rawat, S.G., Tiwari, R.K., Jaiswara, P.K. Jaiswara, V., Sonkar, P., Vishvakarma, N.K., Kumar, S., Pathak, C., Gautam, V., Kumar, A., Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism. Apoptosis 27, 606–618 (2022). https://doi.org/10.1007/s10495-022-01741-0 [Impact Factor 5.561] 2. Verma AK, Hossain MS, Ahmed SKF, Hussain N, Ashid M, Upadhyay SK, Vishvakarma NK, Bhojiya AA & Srivastava SK. (2022) “In silico identification of ethoxy phthalimide pyrazole derivatives as IL-17A and IL-18 targeted gouty arthritis agents”, Journal of Biomolecular Structure and Dynamics, DOI: 10.1080/07391102.2022.2071338 [Impact Factor 4.15] 3. Verma AK, Majid A, Hossain MS, Ahmed SF, Ashid M, Bhojiya AA, Upadhyay SK, Vishvakarma NK and Alam M. 2022. Identification of 1, 2, 4-Triazine and Its Derivatives against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies. Front. Med. Technol. 4:845322. doi: 10.3389/fmedt.2022.845322 4. Mehta A, Kumar Ratre Y, Sharma K, Soni VK, Tiwari AK, Singh RP, Dwivedi MK, Chandra V, Prajapati SK, Shukla D, Vishvakarma NK*. 2021. Interplay of Nutrition and Psychoneuroendocrineimmune Modulation: Relevance for COVID-19 in BRICS Nations. Front Microbiol. 17;(12):769884. [Impact Factor 6.064] 5. Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK*. 2021. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol. 6;(11):738961. doi: 10.3389/fonc.2021.738961. [Impact Factor 5.738] 6. Baghel VS, Shinde S, Sinha V, Pandey SK, Dwivedi S, Singh N, Tiwari AK, Saxena S, Vishvakarma NK*, 2021 Shukla D, Bhatt P, Post-COVID–19 complication and its effect on acute kidney injury. J Renal Endocrinol 7:e18 7. Shinde S, Baghel V, DIxit A, Dixit V, Tiwari A, Pandey S, Dwivedi S, Vishvakarma N*, Shukla, D.. 2021. CYP1A1 rs4646903 T>C and rs1048943 A>G polymorphisms and the risk of colorectal cancer: An updated meta-analysis. Polymorphism. 8, (1-12). 8. Verma AK, Ahmed SF, Hossain MS, Bhojiya AA, Mathur A, Upadhyay SK, Srivastava AK, Vishvakarma NK, Barik M, Rahaman MM, Bahadur NM. 2021. Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin-resistant Staphylococcusaureus. J Biomol Struct Dyn. l 9:1-17. [Impact Factor 4.15] 9. Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. 2021 Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol. ;27(6):449-469). [Impact Factor 5.374] 10. Sinha V, Saxena S, Pandey SK, Dwivedi S, Thakur S, Asea A, Dixit AK, Dixit V, Vishvakarma NK*, Shukla D. 2021. Current Challenges for the Effective Management of the COVID-19 Pandemic. Adv Exp Med Biol. 1353:(131-149). doi: 10.1007/978-3-030-85113-2_8. PMID: 35137372. [Impact Factor 3.650] 11. Sinha V, Shinde S, Saxena S, Thakur S, Walia T, Dixit V, Tiwari AK, Vishvakarma NK, Dwivedi M, Shukla D. 2020. A Comprehensive Review of Diagnostic and Therapeutic Strategies for the Management of Pancreatic Cancer. Crit Rev Oncog. 25(4):381-404). 12. Shinde S, Saxena S, Dixit V, Tiwari AK, Vishvakarma NK*, Shukla D. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy. Crit Rev Oncog. 2020;25(2):95-109. 13. Mehta A, Soni VK, Sharma K, Ratre YK, Shukla D, Singh AK, Vishvakarma NK*. Finding Horcrux of psychiatric symptoms in COVID-19: Deficiencies of amino acids and vitamin D. Asian J Psychiatr. 2021 Jan; 55:102523. [Impact Factor 13.89] 14. Ratre, Y.K., Sarkar, T., Tiwari, A., Jaiswal, A., Mehta, A., Soni, V.K., Ansari, S.M.S., Shukla, D. and Vishvakarma, N.K. *, 2022. Single-cell analysis as a guiding tool to understand drug resistance in cancer: Current opportunities and scope. Polymorphism, 8:(37-55). 15. Soni, V.K., Mehta, A., Sharma, K., Ratre, Y.K., Dwivedi, M., Chaturvedi, N., Shukla, D., Dixit, A.K., Singh, A.K. and Vishvakarma, N.K. *, 2022. Immunity boosters in COVID-19: Reality or myth?. Medicine India, 1. 16. Soni VK, Sharma K, Mehta A, Ratre YK, Kumar S, Shukla D, Vishvakarma NK*. 2020. A physiological link for psychiatric symptoms in COVID-19: Role of amino acid deficiency. Asian J Psychiatr. 53:(102426). [Impact Factor 13.89] 17. Ratre YK, Vishvakarma NK, Bhaskar LVKS, Verma HK. 2020 Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Curr Microbiol.. 77(12):3809-3820). [Impact Factor 3.89] 18. Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK*. 2020. Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur J Pharmacol. 5;(886:173551). [Impact Factor 4.432] 19. Soni VK, Mehta A, Shukla D, Kumar S, Vishvakarma NK*. 2020. Fight COVID-19 depression with immunity booster: Curcumin for psychoneuroimmunomodulation. Asian J Psychiatr. 53:(102378). Doi: doi: 10.1016/j.ajp.2020.102378 [Impact Factor 13.89] 20. Soni VK, Shukla D, Kumar A, Vishvakarma NK*. 2020. Curcumin circumvent lactate-induced chemoresistance in hepatic cancer cells through modulation of hydroxycarboxylic acid receptor-1. Int J Biochem Cell Biol. (123:105752). PMID: 32325281. doi: 10.1016/j.biocel.2020. [Impact Factor 5.085] 21. El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Vishvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R. 2019. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Br J Cancer. 121(7):556-566). [Impact Factor 9.075] 22. Vishvakarma NK*. 2014. Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis. Phytochem Rev (13):717-724). [Impact Factor 7.741] 23. Vishvakarma NK, Kumar A, Singh V, Singh SM. 2013. Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport. Mol. Carcinog. 52:12;(932-945). [Impact Factor 4.784] 24. Vishvakarma NK, Kumar A, Kumar A, Kant S, Bharti AC, Singh SM. 2012. Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. Toxicol. Appl. Pharmacol. 263:(111- 121). [Impact Factor 4.219] 25. Rai RK, Vishvakarma NK, Mohapatra TM, Singh SM. 2012. Augmented macrophage differentiation and polarization of tumor-associated macrophages towards M1 subtype in Listeria-administered tumor-bearing host. 35:7:(544-554); J. Immunother. [Impact Factor 4.912] 26. Kumar A, Vishvakarma NK,Tyagi A, Bharti AC and Singh SM. Anti-neoplastic action of aspirin against a T cell lymphoma involves alteration in tumor microenvironment and regulation of tumor cell survival. Year of Publication: 2012; Volume: 32; Issue No: 1; Page No from: 91; Page No to: 104; Bioscience Reports; ISSN: 1573-4935. [Impact Factor 3.842] 27. Kumar A, Vishvakarma NK, Bharti AC and Singh SM. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host. Year of Publication: 2012; Volume: 48; Issue No: NA; Page No from: 137; Page No to: 144; Blood Cells, Molecules and Diseases ISSN:1079-9796. [Impact Factor 3.039] 28. Vishvakarma NK and Singh SM. 2011. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. Biochimie. 93:10:(1786-1796) [Impact Factor 4.372] 29. Vishvakarma NK and Singh SM. 2011. Mechanisms of tumor growth retardation by modulation of pH regulation in tumor microenvironment of a murine T cell lymphoma. Biomed Pharmacother. 65:1:(27-39). [Impact Factor 7.419] 30. Vishvakarma NK, Kumar A and Singh SM. 2011 Role of curcumin-dependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival. Toxicol Appl Pharmacol. 252:3:(298-306); [Impact Factor 4.46] 31. Vishvakarma NK and Singh SM. 2010. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: implication in antitumor activation of tumor-associated macrophages. Immunol Lett. 134;1;(83-92) [Impact Factor 4.23] 32. Singh MP, Rastogi PC, Srivastava AK and Vishvakarma NK. 2008. Decolorization of Azo-Dye by White Rot Fungi Pleuroteus sp. Pollution Research. 27:3:(365-379) [Impact Factor 1.55] 33. Singh MP, Pandey VK, Pandey AK, Srivastava AK, Vishvakarma NK AND Singh VK. 2008. Production of xylanase by white rot fungi on wheat straw. Asian J. Microbiol Biotechnol Env Sci.Volume: 10:859-862). 34. Tiwari, A.K. Vishvakarma NK, Dixit V, Shukla D. 2017. Seasonal biochemical characterization of muscles, liver and ovary of M. seenghala from Vindhya region. Int. J. Zool. Stud. 2:4:(14-20). 35. Kumari P, Dixit V, Tiwari AK, Saxena S, Vishvakarma NK. Naik, PK and Shukla D. 2018. Computer- assisted drug designing of triazole derivatives of Noscapine as tubuling binding drug. Asian J Pharm Clin Res. 11:(69-75). 36. Mallick SK, Gupta V, Singh MP, Vishvakarma NK, Singh N and Singh SM. 2008. Effect of Neem (Azadirachtaindica) oil on the progressive growth of a spontaneous T cell lymphoma. Orient Pharm Exp Med. 7:5:(459-465). [Impact Factor 0.211] 37. Singh SK, Naik PK, Vishwakarma NK, Dixit V, Tiwari AK, Shukla D. 2015. Identification and ligand-based virtual screening of 1, 4-dihydropyridine analogues as novel calcium channel blockers. PROC. OF THE IRSMT. Int. J. Res. Stud Biosci. 1:(107-114). Guest Editor –Special Issue 1. Regulation of Metabolic Rewiring in T-Cell Malignancies. Frontiers in Oncology. [Impact Factor 5.085] 2. Cancer Imaging and Metabolism. Metabolites –MDPI. [Impact Factor 5.581] Books / Book Chapters Books Edited 1. Colon Cancer Diagnosis and Therapy. Vol I 2021. Editors Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma. Springer Nature. ISBN: 978-3-030-63369-1 2. Colon Cancer Diagnosis and Therapy. Vol II 2021. Editors Naveen Kumar Vishvakarma. Ganji Purnachandra Nagaraju, Dhananjay Shukla, Springer Nature. ISBN: 978-3-030-64667-7 3. Colon Cancer Diagnosis and Therapy. Vol III 2022. Editors Dhananjay Shukla, Naveen Kumar Vishvakarma. Ganji Purnachandra Nagaraju, Springer Nature. ISBN: 978-3-030-72702-4 Chapters in Books 1. Ratre YK, Mehta A, Shinde S, Sinha V, Soni VK, Sonkar SC, Shukla D, Vishvakarma NK*. Molecular Farming and Anticancer Vaccine: Current Opportunities and Openings. In. Microbial Bioreactors for Industrial Molecules. 2023 ISBN: 9781119874065. Wiley 2. Soni VK, Ratre YK, Mehta A, Sonkar SC, Prajapati SK, Chaturvedi N, Shukla D, Vishvakarma NK*. Mushrooms against Malignancies: From Chemosensitization to Immunopotentiation. In. Mushrooms: A Wealth of Nutraceuticals and an Agent of Bioremediation, 2023. 9-34. Bentham Books. 3. Mehta A, Rawat SG, Ratre YK, Soni VK, Shukla D, Kumar A, Vishvakarma NK*. Tumor-associated macrophages in prostate cancer: role in progression and therapy. In. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer. 2023, Pages 153-180 4. Bansal S., Singh K., S. Sarkar, Pandey P. C., Verma J., Yadav M., Chandra L., Vishwkarma N. K., Goswami B., Sonkar S. C. & Koner B. C. Environmental Impact of Sensing Devices. In: Sonker, R.K., Singh, K., Sonkawade, R. (eds) Smart Nanostructure Materials and Sensor Technology. 2022 Springer, Singapore. https://doi.org/10.1007/978-981-19-2685-3_6 5. Baghel VS, Shinde S, Dixit V, Vishvakarma NK, Tiwari AK, Tiwari S, Shukla D. (2022) Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2: Diagnosis, Therapeutic Targets, and Molecular Mechanisms. 337-355. https://doi.org/10.1016/B978-0-323-98807-0.00009-0 6. Sinha V, Shinde S, Baghel VS, Vishvakarma NK, Shukla D, Tiwari AK, Dixit AK, Pandey SK, Dwivedi S, Singh M, Dixit V. (2022) Therapeutic options for the management of hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3: Translational and Clinical Outcomes. Pages 43-62. https://doi.org/10.1016/B978-0-323-99283-1.00018-5 7. Soni VK, Ratre YK, Mehta A, Dixit AK, Dwivedi M, Shukla D, Kumar A, Vishvakarma NK*. Curcumin: a spice pigment against hepatic cancer. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3: Translational and Clinical Outcomes. 141-159 8. Sinha V, Shinde S, Dixit V, Tiwari AK, Dixit AK, Vishvakarma NK, Pandey SK, Ekka A, Singh M & Shukla D (2022). Prevention and Management of Colon Cancer by Nutritional Intervention. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_13 9. Ratre YK, Mehta A, Sharma R, Soni VK, Shukla D, Tripathi VN, Vishvakarma NK*, Chapter 14 – Glutamine metabolism in liver cancer: role in progression and potential therapeutic targeting, Editor(s): Ganji Purnachandra Nagaraju, Sujatha Peela, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Academic Press, 2022, Pages 199-217, 10. Srivastava, R., Sonam, S., Vishvakarma, N.K., Sharma, R., Tiwari, S.P. (2022). Bacterial Cancer Therapy: Promising Role in the Treatment of Colon Cancer. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_17 11. Soni, V.K. Mehta A, Ratre YK, Kumar C, Singh RP, Srivastava AK, Chaturvedi N, Shukla D, Pandey SK, Vishvakarma NK*. (2022). Antineoplastic Effects of Curcumin Against Colorectal Cancer: Application and Mechanisms. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_18 12. Mehta, A. Soni Vk, Ratre YK, Amit A, Shukla S, Kumar A, Vishvakarma NK*. (2022). Role of Tumour-Associated Macrophages in Colon Cancer Progression and Its Therapeutic Targeting. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_10 13. Sinha V, Shinde S, Dixit V, Tiwari AK, Dixit AK, Vishvakarma NK, Pandey SK, Ekka A, Singh M, Shukla D. (2022). Prevention and Management of Colon Cancer by Nutritional Intervention. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_13 14. Kumar S, Vishvakarma NK, Kumar A. Chapter 5 – Clinical applications of noncoding RNAs in lung cancer patients, Editor(s): Subash Chandra Gupta, Kishore B. Challagundla,. Clinical Applications of Noncoding RNAs in Cancer, Academic Press, 2022, Pages 141-175, 15. Rawat, S.G., Tiwari, R.K., Sonker, P., Maurya, R.P., Vishvakarma, N.K., Kumar, A. (2021). EGCG as Anti-Obesity and Anticancer Agent. In: Kumar, S., Gupta, S. (eds) Obesity and Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-16-1846-8_11 16. Gupta, V. Bharmal T, Dixit V, Vishvakarma NK, Tiwari AK, Shukla D, Shukla S. (2021). Targeting Angiogenesis for Colorectal Cancer Therapy. In: Nagaraju, G.P., Shukla, D., Vishvakarma, N.K. (eds) Colon Cancer Diagnosis and Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-63369-1_11 17. Mehta A, Soni VK, Ratre YK, Singh RP, Shukla D, Vishvakarma NK*. (2021). Short-Chain Fatty Acids as Therapeutic Agents in Colon Malignancies. In: Nagaraju, G.P., Shukla, D., Vishvakarma, N.K. (eds) Colon Cancer Diagnosis and Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-63369-1_10 18. Shinde S, Sinha V, Dxit V, Dwivedi MK, Vishvakarma NK, Tiwari AK, Pandey SK, Shukla D. (2021). Dietary Habits and Global Incidence of Colon Cancer. In: Vishvakarma, N.K., Nagaraju, G.P., Shukla, D. (eds) Colon Cancer Diagnosis and Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-64668-4_2 19. Ratre YK, Verma HK, Mehta A, Soni VK, Sonkar SC, Shukla D, Ekka A, Prajapati SK, Mahilkar S, Vishvakarma NK*. (2021). Therapeutic Targeting of Glutamine Metabolism in Colorectal Cancer. In: Vishvakarma, N.K., Nagaraju, G.P., Shukla, D. (eds) Colon Cancer Diagnosis and Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-64668-4_15 20. Shinde S, Vishvakarma NK, Tiwari AK, Dixit V, Saxena S, Shukla D. Chapter 10 – Therapeutic options for the management of cervical cancer, Editor(s): Rama Rao Malla, Ganji Purnachandra Nagaraju, A Theranostic and Precision Medicine Approach for Female-Specific Cancers, Academic Press, 2021, Pages 193-212, 21. Mehta A, Soni VK, Shukla D, Vishvakarma NK*. Cyanobacteria: a potential source of Anticancer Drugs, In: Advances in Cyanobacterial Biology. Editor: PK Singh, Editor(s): Prashant Kumar Singh, Ajay Kumar, Vipin Kumar Singh, Alok Kumar Shrivastava,. Academic Press, 2020, Pages 369-384, 22. Vishvakarma NK. Microbes and cancer: a mutual intimacy. In: Plants and microbes in an ever- changing environment. Editor: Satya Shila Singh. Page No: 365-384; Date of publication: 2017; NOVA Science Publishers, New York, USA. 978-1-53610-3. 23. Vishvakarma NK. Glorious past and promising future of Curcumin based antitumor therapeutic strategies. In; Curcumin: Synthesis, Emerging Role In Pain Management And Health Implications, Editor/ Daniel LoïcPouliquen.; Page No: 395-408; Date of publication: 2014; NOVA Science Publishers, New York, USA International level publishers.978-1-63321-3 24. Vishvakarma NK, Singh SM. Macrophages: The Versatile Frontline Defenders of Antimicrobial Immunity. Editor: S.P. Tiwari, Rajesh Sharma and Rajeeva Gaur. “Recent advances in microbiology”; Vol- II, Page No: 38-53; Date of publication: 05/2013; NOVA Science Publishers, New York, USA. International level publishers.978-1-62808-6. 25. Vishvakarma NK, Srivastava P, Singh SM. Thymic peptides: hormones with biological response modifying potential and multi-utility therapeutic applications in life threatening pathologies. Editor: M.P. Singh, Anju Agrawal, Bechan Sharma. “Recent trends in biotechnology”; Vol-I; Date of publication: 05/2011. Page No: 169-190; NOVA Science Publishers, New York, USA International level publishers. 978-1-60876-1.